- Home
- HESM vs KYMR Comparison
HESM vs KYMR Comparison
Compare HESM & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HESM
- KYMR
- Stock Information
- Founded
- HESM 2014
- KYMR 2015
- Country
- HESM United States
- KYMR United States
- Employees
- HESM N/A
- KYMR N/A
- Industry
- HESM Oil & Gas Production
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- HESM Energy
- KYMR Health Care
- Exchange
- HESM Nasdaq
- KYMR Nasdaq
- Market Cap
- HESM 3.8B
- KYMR 3.0B
- IPO Year
- HESM N/A
- KYMR 2020
- Fundamental
- Price
- HESM $35.36
- KYMR $41.96
- Analyst Decision
- HESM Buy
- KYMR Buy
- Analyst Count
- HESM 3
- KYMR 13
- Target Price
- HESM $38.67
- KYMR $51.15
- AVG Volume (30 Days)
- HESM 751.7K
- KYMR 415.6K
- Earning Date
- HESM 10-30-2024
- KYMR 10-31-2024
- Dividend Yield
- HESM 7.75%
- KYMR N/A
- EPS Growth
- HESM 16.31
- KYMR N/A
- EPS
- HESM 2.37
- KYMR N/A
- Revenue
- HESM $1,456,100,000.00
- KYMR $87,563,000.00
- Revenue This Year
- HESM $12.64
- KYMR N/A
- Revenue Next Year
- HESM $11.26
- KYMR $21.47
- P/E Ratio
- HESM $14.94
- KYMR N/A
- Revenue Growth
- HESM 11.43
- KYMR 86.92
- 52 Week Low
- HESM $30.08
- KYMR $17.89
- 52 Week High
- HESM $39.11
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- HESM 51.34
- KYMR 34.56
- Support Level
- HESM $34.19
- KYMR $45.16
- Resistance Level
- HESM $35.56
- KYMR $53.23
- Average True Range (ATR)
- HESM 0.62
- KYMR 2.58
- MACD
- HESM 0.05
- KYMR -0.54
- Stochastic Oscillator
- HESM 67.03
- KYMR 1.66
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.